IPOdesktop

About the Author IPOdesktop

During the IPO season Francis Gaskins, editor of IPOdesktop.com & director of research for Equities.com, regularly appears on CNBC TV, Bloomberg, thestreet.com & other financial cable channels. On the day of the Visa IPO he appeared on four cable TV financial shows including Bloomberg & CNBC. Over the past five years he has been quoted over 500 times by such financial media as the Wall Street Journal, Bloomberg, Reuters, Associated Press, USA Today among others. Those quotes are available at IPOdesktop.com. His varied personal interests include violin playing. For example, he is concertmaster of the Palisades Symphony. He also holds an MBA from Harvard Business School (finance) and an AB from Princeton University (economics).

IPO Preview: Neff Corporation

Based in Miami, FL, Neff Corporation (Pending:NEFF) scheduled a $220 million IPO on NYSE with a market capitalization of $489 million at a …

IPO Preview: Peak Resorts

Based in Wildwood, MO, Peak Resorts (Pending:SKIS) scheduled a $100 million IPO on Nasdaq with a market capitalization of $140 million at a …

IPO Preview: Neothetics

SummaryTargeting an aesthetic market. Seeking approval of lead product candidate, LIPO-202, for the reduction of central abdominal bulging due to subcutaneous fat in …

IPO Preview: Paramount Group

Based in New York, NY, Paramount Group (Pending:PGRE) scheduled a $2.3 billion IPO on NYSE with a market capitalization of $4.

IPO Preview: STORE Capital Corporation

SummarySTOR is an internally managed net-lease real estate investment trust, or REIT, that is a leader in the acquisition, investment and management of …

IPO Preview: NeuroDerm

SummaryNDRM is a clinical-stage pharmaceutical company developing next-generation treatments for central nervous system, or CNS, disorders through proprietary formulations based on existing drugs …

IPO Preview: FibroGen

FGEN is a research-based, biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic agents to treat serious unmet medical needs. …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts